Diabetes, Vol 45, Issue 6 795-800, Copyright © 1996 by American Diabetes Association

ARTICLES

Cellular immune response to diverse islet cell antigens in IDDM

I Durinovic-Bello, M Hummel and AG Ziegler
Diabetes Research Institute, Academic Hospital Munchen-Schwabing, Germany.

In IDDM, T-cells are postulated to mediate the destruction of pancreatic beta-cells. We analyzed peripheral blood mononuclear cell (PBMC) responses to human insulin, glutamate decarboxylase GAD65, tyrosine phosphatase ICA512, glucagon, membrane preparations of RIN cells and human pancreas, and three control antigens (La = nuclear cell antigen, tetanus toxoid, and phytohemagglutinin). A total of 28 patients with newly diagnosed IDDM, 9 antibody-positive (Ab+) first-degree relatives, and 16 healthy control subjects were included. Increased proliferative responses to pancreatic islet cell antigens were observed in diabetic patients and in Ab+ relatives compared with control subjects, whereas T-cell reactivity to nonpancreatic control antigens was similar between the study groups. The highest differences in the magnitude of proliferative responses were seen for ICA512, followed by membrane preparations of RIN cells, GAD65, and human pancreas. Few subjects reacted with insulin or glucagon. Interestingly, Ab+ relatives showed higher T-cell reactivity with respect to stimulation indexes and prevalences than newly diagnosed diabetic patients, and as many as 89% of Ab+ relatives showed proliferation to more than one islet cell antigen preparation in comparison to 43% of newly diagnosed diabetic patients and none of the control subjects. Statistical analysis revealed significant positive correlation of insulin autoantibody levels with the levels of insulin-specific T-cells in Ab+ relatives, but no relation of PBMC responses to age, sex, or HLA-DR haplotypes. Our results demonstrate the simultaneous existence of various autoreactive T-cells specific for islet cell antigens in the prediabetic period. These T-cells may play a significant role in the pathogenesis of the disease.
CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				A Mayer, N Fabien, M C Gutowski, V Dubois, L Gebuhrer, J Bienvenu, J Orgiazzi, and A M Madec Contrasting cellular and humoral autoimmunity associated with latent autoimmune diabetes in adults Eur. J. Endocrinol., July 1, 2007; 157(1): 53 - 61. [Abstract] [Full Text] [PDF]

				J. Yang, N. A. Danke, D. Berger, S. Reichstetter, H. Reijonen, C. Greenbaum, C. Pihoker, E. A. James, and W. W. Kwok Islet-Specific Glucose-6-Phosphatase Catalytic Subunit-Related Protein-Reactive CD4+ T Cells in Human Subjects. J. Immunol., March 1, 2006; 176(5): 2781 - 2789. [Abstract] [Full Text] [PDF]

				I. Cvetkovic, Y. Al-Abed, D. Miljkovic, D. Maksimovic-Ivanic, J. Roth, M. Bacher, H. Y. Lan, F. Nicoletti, and S. Stosic-Grujicic Critical Role of Macrophage Migration Inhibitory Factor Activity in Experimental Autoimmune Diabetes Endocrinology, July 1, 2005; 146(7): 2942 - 2951. [Abstract] [Full Text] [PDF]

				H. Reijonen, R. Mallone, A.-K. Heninger, E. M. Laughlin, S. A. Kochik, B. Falk, W. W. Kwok, C. Greenbaum, and G. T. Nepom GAD65-Specific CD4+ T-Cells with High Antigen Avidity Are Prevalent in Peripheral Blood of Patients With Type 1 Diabetes Diabetes, August 1, 2004; 53(8): 1987 - 1994. [Abstract] [Full Text] [PDF]

				J. A. Dromey, S. M. Weenink, G. H. Peters, J. Endl, P. J. Tighe, I. Todd, and M. R. Christie Mapping of Epitopes for Autoantibodies to the Type 1 Diabetes Autoantigen IA-2 by Peptide Phage Display and Molecular Modeling: Overlap of Antibody and T Cell Determinants J. Immunol., April 1, 2004; 172(7): 4084 - 4090. [Abstract] [Full Text] [PDF]

				C. J. Greenbaum and L. C. Harrison Guidelines for Intervention Trials in Subjects With Newly Diagnosed Type 1 Diabetes Diabetes, May 1, 2003; 52(5): 1059 - 1065. [Full Text] [PDF]

				M. Arata, L. Bruno, C. Pastorale, F. Pagliero, and J. C. Basabe Effect of Modified Diabetic Splenocytes on Mice Injected with Splenocytes from Multiple Low-Dose Streptozotocin Diabetic Donors Experimental Biology and Medicine, November 1, 2001; 226(10): 898 - 905. [Abstract] [Full Text] [PDF]

				K. Kelemen, D. R. Wegmann, and J. C. Hutton T-Cell Epitope Analysis on the Autoantigen Phogrin (IA-2{beta}) in the Nonobese Diabetic Mouse Diabetes, August 1, 2001; 50(8): 1729 - 1734. [Abstract] [Full Text] [PDF]

				B. Brooks-Worrell, V. H. Gersuk, C. Greenbaum, and J. P. Palmer Intermolecular Antigen Spreading Occurs During the Preclinical Period of Human Type 1 Diabetes J. Immunol., April 15, 2001; 166(8): 5265 - 5270. [Abstract] [Full Text] [PDF]

				S. Winer, I. Astsaturov, R. K. Cheung, L. Gunaratnam, V. Kubiak, M. A. Cortez, M. Moscarello, P. W. O'Connor, C. McKerlie, D. J. Becker, et al. Type I Diabetes and Multiple Sclerosis Patients Target Islet Plus Central Nervous System Autoantigens; Nonimmunized Nonobese Diabetic Mice Can Develop Autoimmune Encephalitis J. Immunol., February 15, 2001; 166(4): 2831 - 2841. [Abstract] [Full Text] [PDF]

				S. Trembleau, G. Penna, S. Gregori, G. Magistrelli, A. Isacchi, and L. Adorini Early Th1 Response in Unprimed Nonobese Diabetic Mice to the Tyrosine Phosphatase-Like Insulinoma-Associated Protein 2, an Autoantigen in Type 1 Diabetes J. Immunol., December 15, 2000; 165(12): 6748 - 6755. [Abstract] [Full Text] [PDF]

				C. Törn, M. Landin-Olsson, A. Lernmark, J. P. Palmer, H. J. Arnqvist, G. Blohmé, F. Lithner, B. Littorin, L. Nyström, B. Scherstén, et al. Prognostic Factors for the Course of {beta} Cell Function in Autoimmune Diabetes J. Clin. Endocrinol. Metab., December 1, 2000; 85(12): 4619 - 4623. [Abstract] [Full Text]

				H.-M. Dosch, R. K. Cheung, W. Karges, M. Pietropaolo, and D. J. Becker Persistent T Cell Anergy in Human Type 1 Diabetes J. Immunol., December 15, 1999; 163(12): 6933 - 6940. [Abstract] [Full Text] [PDF]

				A. Mayer, F. Rharbaoui, C. Thivolet, J. Orgiazzi, and A. M. Madec The Relationship between Peripheral T Cell Reactivity to Insulin, Clinical Remissions and Cytokine Production in Type 1 (Insulin-Dependent) Diabetes Mellitus J. Clin. Endocrinol. Metab., July 1, 1999; 84(7): 2419 - 2424. [Abstract] [Full Text]

				K. Takahashi, M. C. Honeyman, and L. C. Harrison Impaired Yield, Phenotype, and Function of Monocyte-Derived Dendritic Cells in Humans at Risk for Insulin-Dependent Diabetes J. Immunol., September 1, 1998; 161(5): 2629 - 2635. [Abstract] [Full Text] [PDF]

				M Hummel, I Durinovic-Bello, E Bonifacio, V Lampasona, J Endl, S Fessele, F T. Bergh, C Trenkwalder, E Standl, and A-G Ziegler Humoral and cellular immune parameters before and during immunosuppressive therapy of a patient with stiff-man syndrome and insulin dependent diabetes mellitus J. Neurol. Neurosurg. Psychiatry, August 1, 1998; 65(2): 204 - 208. [Abstract] [Full Text]

				M. Congia, S. Patel, A. P. Cope, S. De Virgiliis, and G. Sonderstrup T cell epitopes of insulin defined in HLA-DR4 transgenic mice are derived from preproinsulin and proinsulin PNAS, March 31, 1998; 95(7): 3833 - 3838. [Abstract] [Full Text] [PDF]

				R. H. Slover and G. S. Eisenbarth Prevention of Type I Diabetes and Recurrent {beta}-Cell Destruction of Transplanted Islets Endocr. Rev., April 1, 1997; 18(2): 241 - 258. [Abstract] [Full Text]